Thomas Seyfried: Cancer - A Metabolic Disease With Metabolic Solutions (Ketogenic diet therapy)

Do you want to learn more? Visit our education community: https://skool.com/ketoforcancer

Dr. Thomas Seyfried, discusses cancer as a metabolic disease. He holds a Ph.D. in Genetics and Biochemistry from the University of Illinois and has a background in neurology. Dr. Seyfried has received numerous awards and honors from various organizations, and he has over 150 peer-reviewed publications. He is also the author of the book "Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer," published in 2012.

We are a group of enthusiastic fans, who want to support Prof. Seyfried! Because he never really asks for money... but we know he needs it!

That's why we created this channel: To spread his word and give you the opportunity to give to his research in a lot of different ways! We will post all the newest videos by him in one place, make special edits, post stuff from collegues in the keto-cancer field as well.

You can support him in multiple ways:
Buy his summary book, eBook: https://www.cancer-as-a-metabolic-dis...
Summary book, paperback: https://www.amazon.com/Summary-Metabo...
Buy his scientific book: https://www.amazon.com/Cancer-Metabol...
Donate to his research directly at https://foundationformetaboliccancert...

Cycle 2, Video #6
Date of publication on Youtube:
3.3.2015

SOURCE:
   • Thomas Seyfried: Cancer: A Metabolic ...  

Emerging evidence indicates that cancer is primarily a metabolic disease involving disturbances in energy production through respiration and fermentation. Cancer is suppressed following transfer of the nucleus from the tumor cell to cytoplasm of normal cells containing normal mitochondria. These findings indicate that nuclear genetic abnormalities cannot be responsible for cancer despite commonly held beliefs in the cancer field. The genomic instability observed in tumor cells and all other recognized hallmarks of cancer are considered downstream epiphenomena of the initial disturbance of cellular energy metabolism. The disturbances in tumor cell energy metabolism can be linked to abnormalities in the structure and function of the mitochondria. Cancer growth and progression can be managed following a whole-body transition from fermentable metabolites, primarily glucose and glutamine, to respiratory metabolites, primarily ketone bodies. This transition will reduce tumor vascularity and inflammation while enhancing tumor cell death. A novel “press-pulse” therapeutic strategy is in development for the non-toxic metabolic management of cancer. Malignant brain cancer in preclinical models and humans will be used to illustrate general concepts. As each individual is a unique metabolic entity, personalization of metabolic therapy as a broadbased cancer treatment strategy will require fine-tuning to match the therapy to an individual’s unique physiology.

Thomas N. Seyfried received his Ph.D. in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. He did his undergraduate work at the University of New England, where he recently received the distinguished Alumni Achievement Award. He also holds a Master’s degree in Genetics from Illinois State University. Thomas Seyfried served with distinction in the United States Army’s First Cavalry Division during the Vietnam War and received numerous medals and commendations. He was a Postdoctoral Fellow in the Department of Neurology at the Yale University School of Medicine and then served on the faculty as an Assistant Professor in Neurology. Other awards and honors have come from such diverse organizations as the American Oil Chemists Society, the National Institutes of Health, The American Society for Neurochemistry, and the Ketogenic Diet Special Interest Group of the American Epilepsy Society. Dr. Seyfried previously served as Chair, Scientific Advisory Committee for the National Tay-Sachs and Allied Diseases Association and presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor. Dr. Seyfried has over 150 peer-reviewed publications and is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press).”